EPITHELIOID MESOTHELIOMA
Clinical trials for EPITHELIOID MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new EPITHELIOID MESOTHELIOMA trials appear
Sign up with your email to follow new studies for EPITHELIOID MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Three-Pronged attack tested for aggressive lung cancer
Disease control OngoingThis early-stage study is testing if a three-part treatment plan is safe and feasible for people with operable pleural mesothelioma, a cancer often linked to asbestos exposure. The plan involves chemotherapy plus an immunotherapy drug before surgery, followed by up to a year of t…
Matched conditions: EPITHELIOID MESOTHELIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 20:26 UTC
-
New hope for Tough-to-Treat lung cancer? trial tests adding a Tumor-Starving drug
Disease control OngoingThis study tested if adding a new drug called cediranib to standard chemotherapy (cisplatin and pemetrexed) works better for people with malignant pleural mesothelioma, a serious cancer often linked to asbestos. The trial had two parts: first to find a safe dose of cediranib, the…
Matched conditions: EPITHELIOID MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC